On the first day, patients will complete a medical history form and review our office policy, as well as HIPAA guidelines. The doctor will perform a full consultation that will include a discussion of their medical history followed by a detailed examination. The examination will include a complete orthopedic, neurological, postural, range-of-motion, and several other assessment tests in order to determine if Extracorporeal Shockwave Therapy (ESWT) is the right treatment for their condition.
After the first visit, patients will return in a few days, to assess the success of their first treatment (if any) and apply a second treatment. At this time, patient’s are encouraged to ask questions and be an active learner in fully comprehending their condition.
“I began seeing Dr. Noel after my back became so painful I could barely function. As the therapy program progressed, my neck and back became more pain-free and looser...I am very thankful that after many years of suffering that my condition has improved considerably.” - GeneRead More...
Extracorporeal Shockwave Therapy (ESWT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved Storz Medical's Duolith SD1 -T-TOP device to administer ESWT.
The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.